TREA

85317171 - SOLBRI

Follow

Information

  • Trademark
  • 85317171
  • Serial Number
    85317171
  • Filing Date
    May 10, 2011
    13 years ago
  • Transaction Date
    August 01, 2016
    8 years ago
  • Status Date
    August 01, 2016
    8 years ago
  • Published for Opposition Date
    May 06, 2014
    10 years ago
  • Location Date
    February 12, 2015
    9 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    TENG, SIMON
  • Attorney Docket Number
    VPBV002
    Attorney Name
    Christopher L. Graff
    Law Office Assigned Location Code
    L50
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
SOLBRI
Case File Statements
  • GS0051: Pharmaceutical preparations and substances for the treatment of skin disorders, diseases, conditions and ailments; pharmaceutical preparations and products for use in dermatology; antifungal preparations; pharmaceutical preparations and substances for the treatment of eye disorders, diseases, conditions and ailments; pharmaceutical preparations and products for ophthalmological use; pharmaceutical preparations and substances for the treatment of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety, depression, depressive disorders and mental illness; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardiovascular system; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations and substances for the treatment of infectious diseases; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations and substances for use in chemotherapy; pharmaceutical preparations and substances for use in urology; pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, anti-inflammatories and pain relief medication; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances for the treatment of fungal infections, onychomycosis, tinea infections, and similar diseases of the skin and nails; pharmaceutical preparations and substances for use in dermatological conditions
Case File Event Statements
  • 8/1/2016 - 8 years ago
    58 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Type: MAB6
  • 8/1/2016 - 8 years ago
    57 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 3/3/2016 - 8 years ago
    56 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 1/20/2016 - 8 years ago
    55 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/19/2016 - 8 years ago
    54 - EXTENSION 3 GRANTED Type: EX3G
  • 12/21/2015 - 9 years ago
    53 - EXTENSION 3 FILED Type: EXT3
  • 12/21/2015 - 9 years ago
    52 - TEAS EXTENSION RECEIVED Type: EEXT
  • 7/14/2015 - 9 years ago
    51 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/11/2015 - 9 years ago
    50 - EXTENSION 2 GRANTED Type: EX2G
  • 6/29/2015 - 9 years ago
    49 - EXTENSION 2 FILED Type: EXT2
  • 6/29/2015 - 9 years ago
    48 - TEAS EXTENSION RECEIVED Type: EEXT
  • 2/19/2015 - 9 years ago
    47 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 2/18/2015 - 9 years ago
    46 - EXTENSION 1 GRANTED Type: EX1G
  • 12/18/2014 - 10 years ago
    45 - EXTENSION 1 FILED Type: EXT1
  • 2/12/2015 - 9 years ago
    44 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 1/21/2015 - 9 years ago
    43 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 12/18/2014 - 10 years ago
    42 - TEAS EXTENSION RECEIVED Type: EEXT
  • 7/1/2014 - 10 years ago
    41 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 5/6/2014 - 10 years ago
    40 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/6/2014 - 10 years ago
    39 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/16/2014 - 10 years ago
    38 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/1/2014 - 10 years ago
    37 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 4/1/2014 - 10 years ago
    36 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/13/2014 - 10 years ago
    35 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/12/2014 - 10 years ago
    34 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/12/2014 - 10 years ago
    33 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 1/22/2014 - 10 years ago
    32 - ATTORNEY REVOKED AND/OR APPOINTED Type: ARAA
  • 1/22/2014 - 10 years ago
    31 - TEAS REVOKE/APPOINT ATTORNEY RECEIVED Type: REAP
  • 9/30/2013 - 11 years ago
    30 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 9/30/2013 - 11 years ago
    29 - FINAL REFUSAL E-MAILED Type: GNFR
  • 9/30/2013 - 11 years ago
    28 - FINAL REFUSAL WRITTEN Type: CNFR
  • 9/12/2013 - 11 years ago
    27 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/12/2013 - 11 years ago
    26 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/11/2013 - 11 years ago
    25 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/18/2013 - 11 years ago
    24 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/18/2013 - 11 years ago
    23 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/18/2013 - 11 years ago
    22 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/7/2013 - 11 years ago
    21 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/7/2013 - 11 years ago
    20 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/27/2013 - 11 years ago
    19 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 8/28/2012 - 12 years ago
    18 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2
  • 8/28/2012 - 12 years ago
    17 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI
  • 8/28/2012 - 12 years ago
    16 - SUSPENSION INQUIRY WRITTEN Type: CNSI
  • 8/27/2012 - 12 years ago
    15 - LIE CHECKED SUSP - TO ATTY FOR ACTION Type: RCCK
  • 8/27/2012 - 12 years ago
    14 - ASSIGNED TO LIE Type: ALIE
  • 8/1/2012 - 12 years ago
    13 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 2/24/2012 - 12 years ago
    12 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 2/24/2012 - 12 years ago
    11 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 2/24/2012 - 12 years ago
    10 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 2/23/2012 - 12 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/23/2012 - 12 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/23/2012 - 12 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/24/2011 - 13 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 8/24/2011 - 13 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 8/24/2011 - 13 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/24/2011 - 13 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/16/2011 - 13 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 5/13/2011 - 13 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP